Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 1
2014 1
2015 2
2016 2
2017 3
2018 2
2019 5
2020 5
2021 7
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
A Clinical Case of Probable Sitosterolemia.
Terasaki M, Izumi M, Yamagishi SI. Terasaki M, et al. Int J Mol Sci. 2024 Jan 26;25(3):1535. doi: 10.3390/ijms25031535. Int J Mol Sci. 2024. PMID: 38338819 Free PMC article.
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.
Hirano T, Hayashi T, Sugita H, Tamasawa A, Goto S, Tomoyasu M, Yamamoto T, Ohara M, Terasaki M, Kushima H, Ito Y, Yamagishi SI, Mori Y. Hirano T, et al. Among authors: terasaki m. J Diabetes Investig. 2023 Dec;14(12):1401-1411. doi: 10.1111/jdi.14076. Epub 2023 Aug 30. J Diabetes Investig. 2023. PMID: 37647503 Free PMC article. Clinical Trial.
Anti-inflammatory and atheroprotective properties of glucagon.
Osaka N, Kushima H, Mori Y, Saito T, Hiromura M, Terasaki M, Yashima H, Ohara M, Fukui T, Matsui T, Hirano T, Yamagishi SI. Osaka N, et al. Among authors: terasaki m. Diab Vasc Dis Res. 2020 May-Jun;17(5):1479164120965183. doi: 10.1177/1479164120965183. Diab Vasc Dis Res. 2020. PMID: 33076703 Free PMC article.
Increased blood pressure in nesfatin/nuclebindin-2-transgenic mice.
Mori Y, Shimizu H, Kushima H, Hiromura M, Terasaki M, Tanaka M, Osaki A, Hirano T. Mori Y, et al. Among authors: terasaki m. Hypertens Res. 2017 Oct 5;40(10):861-867. doi: 10.1038/hr.2017.61. Epub 2017 Apr 27. Hypertens Res. 2017. PMID: 28446807
Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study.
Omachi T, Ohara M, Fujikawa T, Kohata Y, Sugita H, Irie S, Terasaki M, Mori Y, Fukui T, Yamagishi SI. Omachi T, et al. Among authors: terasaki m. Diabetes Ther. 2024 Jan;15(1):111-126. doi: 10.1007/s13300-023-01493-3. Epub 2023 Oct 25. Diabetes Ther. 2024. PMID: 37880502 Free PMC article.
In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system.
Chu L, Terasaki M, Mattsson CL, Teinturier R, Charbord J, Dirice E, Liu KC, Miskelly MG, Zhou Q, Wierup N, Kulkarni RN, Andersson O. Chu L, et al. Among authors: terasaki m. Cell Chem Biol. 2022 Sep 15;29(9):1368-1380.e5. doi: 10.1016/j.chembiol.2022.08.001. Epub 2022 Aug 22. Cell Chem Biol. 2022. PMID: 35998625 Free PMC article.
39 results